Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Peen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|July 11, 1988
[Should cervical cytological smears be taken with cotton swabs or a brush?]A Glenthøj, F Rank, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Gynecologic Oncology|December 12, 2019
Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignanciesI B Vergote, B Lund, U Peen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|July 11, 1988
[Should cervical cytological smears be taken with cotton swabs or a brush?]A Glenthøj, F Rank, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Gynecologic Oncology|December 12, 2019
Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignanciesI B Vergote, B Lund, U Peen, et al.
Pageof 1